North America Monoclonal Antibodies (mAbs) Market 2022-2030 by Source (Human, Humanized, Chimeric, Murine), Category (Branded, Biosimilar), Production Type (In Vitro, In Vivo), Application (Cancer, Autoimmune, Inflammatory), End User, and Country: Trend Forecast and Growth Opportunity
- Report ID: 29709
- Date: Jun, 2022
- Pages: 102
- Category: Healthcare & Pharmaceuticals
North America monoclonal antibodies market is projected to grow by 10.4% annually in the forecast period and reach $133.4 billion by 2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies.
Highlighted with 24 tables and 48 figures, this 102-page report “North America Monoclonal Antibodies (mAbs) Market 2020-2030 by Source (Human, Humanized, Chimeric, Murine), Category (Branded, Biosimilar), Production Type (In Vitro, In Vivo), Application (Cancer, Autoimmune, Inflammatory), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America monoclonal antibodies market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America monoclonal antibodies market in every aspect of the classification from perspectives of Source, Category, Production Type, Application, End User, and Country.
Based on Source, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Human
• Humanized
• Chimeric
• Murine
Based on Category, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Branded mAbs
• Biosimilar mAbs
Based on Production Type, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• In Vitro Production
• In Vivo Production
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Cancer
o Breast Cancer
o Colorectal Cancer
o Lung Cancer
o Ovarian Cancer
o Other Cancer Types
• Autoimmune Diseases
• Inflammatory Diseases
• Infectious Diseases
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Hospitals
• Research Institutes
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of key national markets by Source, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
AbbVie, Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Eli Lilly
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V
Norvatis AG
Pfizer
Sanofi S.A.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Source 40
3.1 Market Overview by Source 40
3.2 Human 42
3.3 Humanized 43
3.4 Chimeric 44
3.5 Murine 45
4 Segmentation of North America Market by Category 46
4.1 Market Overview by Category 46
4.2 Branded mAbs 48
4.3 Biosimilar mAbs 49
5 Segmentation of North America Market by Production Type 50
5.1 Market Overview by Production Type 50
5.2 In Vitro Production 52
5.3 In Vivo Production 53
6 Segmentation of North America Market by Application 54
6.1 Market Overview by Application 54
6.2 Cancer 56
6.2.1 Breast Cancer 58
6.2.2 Colorectal Cancer 59
6.2.3 Lung Cancer 60
6.2.4 Ovarian Cancer 61
6.2.5 Other Cancer Types 62
6.3 Autoimmune Diseases 63
6.4 Inflammatory Diseases 64
6.5 Infectious Diseases 65
6.6 Other Applications 66
7 Segmentation of North America Market by End User 67
7.1 Market Overview by End User 67
7.2 Hospitals 69
7.3 Research Institutes 70
7.4 Other End Users 71
8 North America Market 2019-2030 by Country 72
8.1 Overview of North America Market 72
8.2 U.S. 75
8.3 Canada 78
8.4 Mexico 80
9 Competitive Landscape 82
9.1 Overview of Key Vendors 82
9.2 New Product Launch, Partnership, Investment, and M&A 85
9.3 Company Profiles 86
Abbott Laboratories 86
AbbVie, Inc. 88
Amgen Inc. 89
AstraZeneca plc 90
Bayer AG 91
Bristol-Myers Squibb Company 92
Eli Lilly 93
F. Hoffmann-La Roche Ltd. 94
GlaxoSmithKline Plc 95
Johnson & Johnson 96
Merck & Co., Inc. 97
Mylan N.V 98
Norvatis AG 99
Pfizer 100
Sanofi S.A. 101
RELATED REPORTS 102
List of Tables
Table 1. Snapshot of North America Monoclonal Antibodies Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in North America Monoclonal Antibodies Market 32
Table 5. North America Monoclonal Antibodies Market by Source, 2019-2030, $ bn 40
Table 6. North America Monoclonal Antibodies Market by Category, 2019-2030, $ bn 46
Table 7. North America Monoclonal Antibodies Market by Production Type, 2019-2030, $ bn 50
Table 8. North America Monoclonal Antibodies Market by Application, 2019-2030, $ bn 54
Table 9. North America Monoclonal Antibodies Market: Cancer Therapy by Type, 2019-2030, $ bn 57
Table 10. North America Monoclonal Antibodies Market by End User, 2019-2030, $ bn 67
Table 11. North America Monoclonal Antibodies Market by Country, 2019-2030, $ bn 73
Table 12. U.S. Monoclonal Antibodies Market by Source, 2019-2030, $ bn 77
Table 13. U.S. Monoclonal Antibodies Market by Application, 2019-2030, $ bn 77
Table 14. U.S. Monoclonal Antibodies Market by End User, 2019-2030, $ bn 77
Table 15. Canada Monoclonal Antibodies Market by Source, 2019-2030, $ bn 79
Table 16. Canada Monoclonal Antibodies Market by Application, 2019-2030, $ bn 79
Table 17. Canada Monoclonal Antibodies Market by End User, 2019-2030, $ bn 79
Table 18. Mexico Monoclonal Antibodies Market by Source, 2019-2030, $ bn 81
Table 19. Mexico Monoclonal Antibodies Market by Application, 2019-2030, $ bn 81
Table 20. Mexico Monoclonal Antibodies Market by End User, 2019-2030, $ bn 81
Table 21. Abbott Laboratories: Company Snapshot 86
Table 22. Abbott Laboratories: Business Segmentation 86
Table 23. Abbott Laboratories: Product Portfolio 87
Table 24. Abbott Laboratories: Revenue, 2018-2020, $ bn 87
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Monoclonal Antibodies Market, 2019-2030, $ bn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of North America Monoclonal Antibodies Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of North America Monoclonal Antibodies Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of North America Monoclonal Antibodies Market 36
Figure 12. Breakdown of North America Monoclonal Antibodies Market by Source, 2019-2030, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2021-2030 by Source, Value ($ bn) and Share (%) 41
Figure 14. North America Monoclonal Antibodies Market by Source: Human, 2019-2030, $ bn 42
Figure 15. North America Monoclonal Antibodies Market by Source: Humanized, 2019-2030, $ bn 43
Figure 16. North America Monoclonal Antibodies Market by Source: Chimeric, 2019-2030, $ bn 44
Figure 17. North America Monoclonal Antibodies Market by Source: Murine, 2019-2030, $ bn 45
Figure 18. Breakdown of North America Monoclonal Antibodies Market by Category, 2019-2030, % of Sales Revenue 47
Figure 19. North America Addressable Market Cap in 2021-2030 by Category, Value ($ bn) and Share (%) 47
Figure 20. North America Monoclonal Antibodies Market by Category: Branded mAbs, 2019-2030, $ bn 48
Figure 21. North America Monoclonal Antibodies Market by Category: Biosimilar mAbs, 2019-2030, $ bn 49
Figure 22. Breakdown of North America Monoclonal Antibodies Market by Production Type, 2019-2030, % of Sales Revenue 51
Figure 23. North America Addressable Market Cap in 2021-2030 by Production Type, Value ($ bn) and Share (%) 51
Figure 24. North America Monoclonal Antibodies Market by Production Type: In Vitro Production, 2019-2030, $ bn 52
Figure 25. North America Monoclonal Antibodies Market by Production Type: In Vivo Production, 2019-2030, $ bn 53
Figure 26. Breakdown of North America Monoclonal Antibodies Market by Application, 2019-2030, % of Revenue 55
Figure 27. North America Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 55
Figure 28. North America Monoclonal Antibodies Market by Application: Cancer, 2019-2030, $ bn 56
Figure 29. North America Monoclonal Antibodies Market by Cancer Type: Breast Cancer, 2019-2030, $ bn 58
Figure 30. North America Monoclonal Antibodies Market by Cancer Type: Colorectal Cancer, 2019-2030, $ bn 59
Figure 31. North America Monoclonal Antibodies Market by Cancer Type: Lung Cancer, 2019-2030, $ bn 60
Figure 32. North America Monoclonal Antibodies Market by Cancer Type: Ovarian Cancer, 2019-2030, $ bn 61
Figure 33. North America Monoclonal Antibodies Market by Cancer Type: Other Cancer Types, 2019-2030, $ bn 62
Figure 34. North America Monoclonal Antibodies Market by Application: Autoimmune Diseases, 2019-2030, $ bn 63
Figure 35. North America Monoclonal Antibodies Market by Application: Inflammatory Diseases, 2019-2030, $ bn 64
Figure 36. North America Monoclonal Antibodies Market by Application: Infectious Diseases, 2019-2030, $ bn 65
Figure 37. North America Monoclonal Antibodies Market by Application: Other Applications, 2019-2030, $ bn 66
Figure 38. Breakdown of North America Monoclonal Antibodies Market by End User, 2019-2030, % of Revenue 68
Figure 39. North America Addressable Market Cap in 2021-2030 by End User, Value ($ bn) and Share (%) 68
Figure 40. North America Monoclonal Antibodies Market by End User: Hospitals, 2019-2030, $ bn 69
Figure 41. North America Monoclonal Antibodies Market by End User: Research Institutes, 2019-2030, $ bn 70
Figure 42. North America Monoclonal Antibodies Market by End User: Other End Users, 2019-2030, $ bn 71
Figure 43. Breakdown of North America Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue 73
Figure 44. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 74
Figure 45. U.S. Monoclonal Antibodies Market, 2019-2030, $ bn 76
Figure 46. Canada Monoclonal Antibodies Market, 2019-2030, $ bn 78
Figure 47. Monoclonal Antibodies Market in Mexico, 2019-2030, $ bn 80
Figure 48. Growth Stage of North America Monoclonal Antibodies Industry over the Forecast Period 82
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
